You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Bavarian Nordic receives European approval of vaccine label Imvanex

Bavarian Nordic has announced that the European Commission (EC) has extended the marketing authorization for the company’s smallpox vaccine, Imvanex. The treatment will also include protection from monkeypox and disease caused by vaccinia virus.